Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. OTC Markets
  5. GB Sciences, Inc.
  6. News
  7. Summary
    GBLX   US3615441090

GB SCIENCES, INC.

(GBLX)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

GB Sciences, Inc. Announces Executive Changes

06/16/2021 | 03:34pm EDT

GB Sciences, Inc. announced that effective June 16, 2021, the board of directors of the company appointed Dr. Andrea Small-Howard President of the Company. Also, effective June 16, 2021, John Poss resigned his position as President, allowing for the appointment of Dr. Small-Howard. Mr. Poss will continue to serve as Chief Executive Officer and as Chairman of the Board of Directors. Dr. Small-Howard will also continue to serve as the company’s Chief Science Officer.


ę S&P Capital IQ 2021
All news about GB SCIENCES, INC.
09/14Gb Sciences Achieves Positive Proof-of-Concept Results for Their Cytokine Release Syndr..
GL
09/14GB Sciences Achieves Positive Proof-of-Concept Results for Their Cytokine Release Syndr..
CI
09/09Gb Sciences Presenting COVID-Related Cytokine Release Syndrome Results at H.C. Wainwrig..
GL
08/23GB SCIENCES INC : Other Events (form 8-K)
AQ
08/13GB SCIENCES : Management's Discussion and Analysis of Financial Condition and Results of O..
AQ
07/06GB SCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF O..
AQ
07/06Gb Sciences, Inc. Reports Earnings Results for the Full Year Ended March 31, 2021
CI
06/16GB SCIENCES INC : Change in Directors or Principal Officers (form 8-K)
AQ
06/16GB SCIENCES : Resignation and Appointment of Certain Officers (Form 8-K)
PU
06/16GB Sciences, Inc. Announces Executive Changes
CI
More news
Financials (USD)
Sales 2021 - - -
Net income 2021 -3,73 M - -
Net Debt 2021 3,18 M - -
P/E ratio 2021 -4,75x
Yield 2021 -
Capitalization 11,6 M 11,6 M -
EV / Sales 2020 -
EV / Sales 2021 -
Nbr of Employees 23
Free-Float 86,5%
Chart GB SCIENCES, INC.
Duration : Period :
GB Sciences, Inc. Technical Analysis Chart | GBLX | US3615441090 | MarketScreener
Income Statement Evolution
Managers and Directors
John Claybron Poss Chairman & Chief Executive Officer
Andrea Small-Howard President, Director & Chief Science Officer
Zach Swarts Chief Financial Officer & Treasurer
Edmond A. DeFrank Independent Director
Gary R. Henrie Secretary
Sector and Competitors
1st jan.Capi. (M$)
GB SCIENCES, INC.-12.99%12
MODERNA, INC.311.74%173 624
LONZA GROUP AG30.56%59 611
IQVIA HOLDINGS INC.46.01%50 128
CELLTRION, INC.-23.54%31 745
SEAGEN INC.-7.88%29 353